Seoul Pharma Co., Ltd (KOSDAQ:018680)

Seoul Pharma Revenue

Seoul Pharma had revenue of 12.01B KRW in the quarter ending June 30, 2025, a decrease of -6.55%. This brings the company's revenue in the last twelve months to 52.20B, down -1.64% year-over-year. In the year 2024, Seoul Pharma had annual revenue of 53.58B with 2.14% growth.

• Revenue (ttm): 52.20B
• Revenue Growth: -1.64%
• P/S Ratio: 0.70
• Revenue / Employee: 303.46M
• Employees: 172
• Market Cap: 36.32B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	53.58B	1.12B	2.14%
Dec 31, 2023	52.46B	2.40B	4.80%
Dec 31, 2022	50.06B	9.59B	23.71%
Dec 31, 2021	40.46B	-11.77B	-22.53%
Dec 31, 2020	52.23B	-1.72B	-3.19%